Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Correspondence to Dr Juliana S Oliveira, Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales 2050, Australia; juliana.oliveira{at}sydney.edu.au Intervention Intervention ...
Objectives To evaluate the efficacy of a new multicomponent, exercise-based injury prevention programme in football players 13–19 years old. Methods Two-arm cluster-randomised controlled trial with ...
Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma. ONITT: A phase I study of nanoliposomal irinotecan with talazoparib ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results